Telithromycin post-antibiotic and post-antibiotic sub-MIC effects for 10 gram-positive cocci

Journal of Antimicrobial Chemotherapy

Volumn 52, Issue 5, 2003, Pages 809-812

  Jacobs, Michael R ^a   Bajaksouzian, Saralee ^a   Appelbaum, Peter C ^b  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

Ketolides; PAEs; Post Antibiotic effects; Staphylococci; Streptococci

Indexed keywords

ANTIBIOTIC AGENT; CLINDAMYCIN; ERYTHROMYCIN; KETOLIDE; LINCOSAMIDE; MACROLIDE; METHYLTRANSFERASE; TELITHROMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; CONTROLLED STUDY; DRUG EXPOSURE; DRUG MECHANISM; GRAM POSITIVE BACTERIUM; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; RIBOSOME; SPECIES COMPARISON; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS PYOGENES;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; CLINDAMYCIN; COLONY COUNT, MICROBIAL; DRUG RESISTANCE, BACTERIAL; ERYTHROMYCIN; GRAM-POSITIVE COCCI; HUMANS; KETOLIDES; MACROLIDES; MICROBIAL SENSITIVITY TESTS; STAPHYLOCOCCUS; STREPTOCOCCUS;

EID: 0242521398     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dkg437     Document Type: Article

References (22)

1. Schulin, T., Wennersten, C. B., Moellering, R. C., Jr et al. (1997). In vitro activity of RU-64004, a new ketolide antibiotic, against gram-positive bacteria. Antimicrobial Agents and Chemotherapy 41, 1196-202.
2. Seppälä, H., Nissinen, A., Yu, Q. et al. (1993). Three different phenotypes of erythromycin-resistant Streptococcus pyogenes in Finland. Journal of Antimicrobial Chemotherapy 32, 885-91.
3. Roberts, M. C., Sutcliffe, J., Courvalin, P. et al. (1999). Nomenclature for macrolide and macrolide-lincosamide-streptogramin B resistance determinants. Antimicrobial Agents and Chemotherapy 43, 2823-30.
4. Weisblum, B. (1995). Insights into erythromycin action from studies of its activity as inducer of resistance. Antimicrobial Agents and Chemotherapy 39, 797-805.
5. Sutcliffe, J., Tait-Kamradt, A. & Wondrack, J. (1996). Streptococcus pneumoniae and Streptococcus pyogenes resistant to macrolides but sensitive to clindamycin: a common resistance pattern mediated by an efflux system. Antimicrobial Agents and Chemotherapy 40, 1817-24.
6. Nagai, K., Appelbaum, P. C., Davies, T. A. et al. (2002). Susceptibilities to telithromycin and six other agents and prevalence of macrolide resistance due to L4 ribosomal protein mutation among 992 pneumococci from 10 central and Eastern European countries. Antimicrobial Agents and Chemotherapy 46, 371-7.
7. Ednie, L. M., Spangler, S. K., Jacobs, M. R. et al. (1997). Susceptibility of 228 penicillin- and erythromycin-susceptible and -resistant pneumococci to RU 64004, a new ketolide, compared with susceptibilities to 16 other agents. Antimicrobial Agents and Chemotherapy 41, 1033-6.
8. Ednie, L. M., Jacobs, M. R. & Appelbaum, P. C. (1997). Comparative antianaerobic activities of the ketolides HMR 3647 (RU 66647) and HMR 3004 (RU-64004). Antimicrobial Agents and Chemotherapy 41, 2019-22.
9. Jamjian, C., Biedenbach, D. J. & Jones, R. N. (1997). In vitro evaluation of a novel ketolide antimicrobial agent, RU-64004. Antimicrobial Agents and Chemotherapy 41, 454-9.
10. Jones, R. N. & Biedenbach, D. J. (1997). Antimicrobial activity of RU-66647, a new ketolide. Diagnostic Microbiology and Infectious Disease 27, 7-12.
11. Douthwaite, S. & Champney, W. S. (2001). Structures of ketolides and macrolides determine their mode of interaction with the ribosomal target site. Journal of Antimicrobial Chemotherapy 48, Suppl. T1, 1-8.
12. Ackermann, G. & Rodloff, A. C. (2003). Drugs of the 21st century: telithromycin (HMR 3647) - the first ketolide. Journal of Antimicrobial Chemotherapy 51, 497-511.
13. Craig, W. A. & Gudmundsson, S. (1996). Postantibiotic effect. In Antibiotics in Laboratory Medicine (Lorian, V., Ed.), pp. 296-329. Williams and Wilkins, Baltimore, MD, USA.
14. MacKenzie, F. M. & Gould, I. M. (1993). The post-antibiotic effect. Journal of Antimicrobial Chemotherapy 32, 519-37.
15. Craig, W. (1993). Pharmacodynamics of antimicrobial agents as a basis for determining dosage regimens. European Journal of Clinical Microbiology and Infectious Diseases 12, Suppl. 1, S6-S8.
16. Kikuchi, K., Enari, T., Minami, S. et al. (1994). Postantibiotic effects and postantibiotic sub-MIC effects of benzylpenicillin on viridans streptococci isolated from patients with infective endocarditis. Journal of Antimicrobial Chemotherapy 34, 687-96.
17. Odenholt-Tornqvist, I. (1993). Studies on the postantibiotic effect and the postantibiotic sub-MIC effect of meropenem. Journal of Antimicrobial Chemotherapy 31, 881-92.
18. Odenholt-Tornqvist, I., Löwdin, E. & Cars, O. (1991). Pharmacodynamic effects of subinhibitory concentrations of β-lactam antibiotics in vivo. Antimicrobial Agents and Chemotherapy 35, 1834-9.
19. Odenholt-Tornqvist, I., Löwdin, E. & Cars, O. (1992). Postantibiotic sub-MIC effects of vancomycin, roxithromycin, sparfloxacin, and amikacin. Antimicrobial Agents and Chemotherapy 36, 1852-8.
20. Montanari, M. P., Mingoia, M., Giovanetti, E. et al. (2001). Differentiation of resistance phenotypes among erythromycin-resistant pneumococci. Journal of Clinical Microbiology 39, 1311-5.
21. National Committee for Clinical Laboratory Standards. (1996). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically - Fourth Edition: Approved Standard M7-A4. NCCLS, Villanova, PA, USA.
22. Giovanetti, E., Montanari, M. P., Mingoia, M. et al. (1999). Phenotypes and genotypes of erythromycin-resistant Streptococcus pyogenes strains in Italy and heterogeneity of inducibly resistant strains. Antimicrobial Agents and Chemotherapy 43, 1935-40.